Original language | English |
---|---|
Pages (from-to) | 1015-1016 |
Number of pages | 2 |
Journal | Neuro-Oncology |
Volume | 25 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Jun 2023 |
Bibliographical note
Funding Information:There was no manuscript-targeted external funding. Outside of the submitted work, ABL was supported in part by The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital, the Hearst Foundations, and by NIH/NCI/NCATS grants P30CA013696 and UL1TR001873. Publication costs were paid by The Michael Weiner Glioblastoma Research Into Treatment Fund.
Funding Information:
There was no manuscript-targeted external funding. Outside of the submitted work, ABL was supported in part by The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at New York-Presbyterian Hospital, the Hearst Foundations, and by NIH/NCI/NCATS grants P30CA013696 and UL1TR001873. Publication costs were paid by The Michael Weiner Glioblastoma Research Into Treatment Fund.